Business Context and Reporting Period
This Form 8-K was filed by Eton Pharmaceuticals, Inc. on April 13, 2021, reporting events occurring on April 12, 2021. The company is a Delaware corporation and an emerging growth company listed on the NASDAQ Global Market under the symbol ETON.
Key Financial Metrics
The filing details a secondary public offering of common stock by a selling stockholder, Harrow Health, Inc. Eton Pharmaceuticals, Inc. did not receive any proceeds from this transaction.
- Shares Sold: 1,518,000 shares of Common Stock (including 198,000 shares from the full exercise of the underwriter's over-allotment option).
- Offering Price: $7.00 per share.
- Gross Proceeds to Selling Stockholder: Approximately $10.63 million (before underwriting discounts and expenses).
- Proceeds to Company: $0.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this report focuses solely on the equity transaction.
Material Changes
The primary material event is the closing of the public offering of shares held by Harrow Health, Inc. This transaction results in a change in the company's shareholder structure but does not directly impact the company's balance sheet or cash position as the company was not the seller of the shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies related to the company's operations were disclosed in this report, other than the standard disclosure of the equity sale.
Investor Verification Checklist
- Verify the updated share count and ownership percentage of Harrow Health, Inc. following the sale of 1,518,000 shares.
- Confirm that the company received no capital from this transaction to ensure accurate cash flow projections.
- Review the underwriting agreement details to understand the discount and expenses borne by the selling stockholder.
- Check subsequent filings for any dilution impact on existing shareholders due to the increased float.